Forge Biologics is hosting a panel discussion titled Scaling Downstream Processes: From Lab to GMP Manufacturing on September 23rd at 2:00 PM EST in Boston
Public source
Publisher name
Public post
Headed to BioProcess International? Don't miss this session! Forge Downstream Process Development Scientist Catherine Spanoudis will join the "Scaling Downstream Process…
Company
Forge Biologics
A member of Ajinomoto Bio-Pharma Services
- Industry
- Biotechnology Research
- Location
- Columbus, US
- Company size
- 201–500 employees
About Forge Biologics
Forge, a member of Ajinomoto Bio-Pharma Services, is a gene therapy development engine, focused on enabling access to life changing gene therapies and helping bring them from idea into reality. We partner with innovators in the gene therapy community: scientists, physicians, biotech/pharma companies, and patient groups. We bring expertise in gene therapy manufacturing and therapeutics development to the table, helping champion teams that are navigating the long road from the lab bench to the bedside. With a patients-first approach, we are forging new models for working together to better accelerate these transformative medicines to reach those who need them most.
See moreLatest activity
Latest activity from Forge Biologics
6 signals
People
Forge Biologics is hiring a Director, Quality Control (Raw Materials) to drive strategic direction and tactical execution of QC Raw Materials.
Presence & Recognition
Forge Biologics released its first Bench Strength podcast episode featuring David Dismuke and Maritza McIntyre.
Presence & Recognition
Forge Biologics announced its upcoming fall conference slate including stops in Phoenix for ARM's Meeting on the Mesa and Hamburg for the ESGCT annual meeting.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Repligen Corporation
Repligen Corporation is hosting the Repligen Day of Innovation Workshop in Copenhagen on 23rd September 2026 to explore practical bioprocessing strategies, process analytics, TFF, and fluid management technologies.
Presence & Recognition
Just - Evotec Biologics
Just - Evotec Biologics is presenting an Accelerating Cell Line Development session on Wednesday, 23 September at the BPI East 2026 event.
Presence & Recognition
ProBio
ProBio is attending the BioProcess International 2026 conference in Boston from September 22 to 25, featuring Booth 931 to discuss development and manufacturing strategies for advanced biologics and cell and gene therapies.
Presence & Recognition
Cytiva
Cytiva is hosting a scale-up event on 15 September to explore a practical framework for transient AAV scale-up, including process development, manufacturing scale, and collaboration with MilliporeSigma's viral vector CDMO.
Presence & Recognition
Single Use Support